Farag F. Sherbiny

发表

Homology modelling of the human adenosine A2B receptor based on X-ray structures of bovine rhodopsin, the β2-adrenergic receptor and the human adenosine A2A receptor

Farag F. Sherbiny, Anke C. Schiedel, Astrid Maaß, 2009, J. Comput. Aided Mol. Des..

The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.

Farag F. Sherbiny, A. Schiedel, C. Müller, 2013, Biochemical pharmacology.

Hydrazone-based Materials; DFT, TD-DFT, NBO Analysis, Fukui Function, MESP Analysis, and Solar Cell Applications

Farag F. Sherbiny, A. A. El-Etrawy, Mahmoud A. S. Sakr, 2022, Journal of Fluorescence.

SYNTHESIS, BIOLOGICAL EVALUATION AND BINDING STUDIES OF NEW FLAVONE DERIVATIVES AS ADENOSINE A2B RECEPTOR ANTAGONISTS

Farag F. Sherbiny, 2016 .

Pharmacophore-linked pyrazolo[3,4-d]pyrimidines as EGFR-TK inhibitors: Synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies.

Farag F. Sherbiny, Rogy R Ezz Eldin, Marwa A Saleh, 2021, Archiv der Pharmazie.

DESIGN AND OPTIMIZATION OF CAPTOPRIL SUBLINGUAL TABLETS: ENHANCEMENT OF PHARMACOKINETIC PARAMETERS IN HUMAN

Farag F. Sherbiny, A. Zaky, Hossam Kadry, 2016 .

PROLIFERATIVE EVALUATION OF NOVEL PYRAZOLO[4,3- E][1,2,4]TRIAZOLO[4,3-C]PYRIMIDINE DERIVATIVES AS POTENTIAL DNA INTERCALATORS AND TOPOISOMERASE II INHIBITORS

Farag F. Sherbiny, A. Gaber, E. Elkaeed, 2020 .

Design, synthesis and antimicrobial evaluation of some novel quinoline derivatives

Farag F. Sherbiny, I. Eissa, Kamal M El-Gamal, 2015 .

Design, synthesis, molecular modeling and biological evaluation of novel 2,3-dihydrophthalazine-1,4-dione derivatives as potential anticonvulsant agents

Farag F. Sherbiny, M. M. Khalifa, I. Eissa, 2017 .

SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL PYRAZOLO[3,4-D]PYRIMIDINE DERIVATIVES OF EXPECTED ANTICANCER ACTIVITY

Farag F. Sherbiny, 2021, Al-Azhar Journal of Pharmaceutical Sciences.

Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through inhibition of STAT3: synthesis and in silico mechanistic studies

Farag F. Sherbiny, Khaled El-Adl, Hamada S. Abulkhair, 2020, Molecular Diversity.

Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through inhibition of STAT3: synthesis and in silico mechanistic studies

Farag F. Sherbiny, Khaled El-Adl, Hamada S. Abulkhair, 2020, Molecular Diversity.

Development of fluorinated nicotinonitriles and fused candidates as antimicrobial, antibiofilm, and enzyme inhibitors

Farag F. Sherbiny, M. Ismail, Shereen M. El kiki, 2022, Archiv der Pharmazie.

Design, synthesis, biological evaluation and molecular modeling investigation of new N'-(2-Thiouracil-5-oyl) hydrazone derivatives as potential anti-breast cancer and anti-bacterial agents

Farag F. Sherbiny, A. A. El-Etrawy, 2021 .

Novel 1,2,4‐triazole derivatives: Design, synthesis, anticancer evaluation, molecular docking, and pharmacokinetic profiling studies

Farag F. Sherbiny, Hany E. A. Ahmed, Hamada S. Abulkhair, 2020, Archiv der Pharmazie.

Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFRWT and EGFRT790M inhibitors and apoptosis inducers.

Farag F. Sherbiny, I. Eissa, Ahmed B. M. Mehany, 2018, Bioorganic chemistry.

Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1,2,4]triazolo[4,3-a]quinoxaline analogues targeting DHFR and E. coli DNA gyrase B.

Farag F. Sherbiny, Hany E. A. Ahmed, T. H. Afifi, 2020, Bioorganic chemistry.

DESIGN , SYNTHESIS AND EV 0 ALUATION OF SOME NEW SCHIFF BASE DERIVATIVES AS POTENTIAL ANTIMICROBIAL AGENTS

Farag F. Sherbiny, 2019 .

Synthesis , molecular docking and antimicrobial evaluation of some novel quinoline-3-carbaldehyde derivatives

Farag F. Sherbiny, Eissa, Hamada S. Abulkhair, 2016 .

Synthesis, characterization and molecular docking studies of thiouracil derivatives as potent thymidylate synthase inhibitors and potential anticancer agents

Farag F. Sherbiny, I. Eissa, A. M. El-Naggar, 2017, Molecular Diversity.

Design, synthesis, and molecular docking studies of new [1,2,4]triazolo[4,3-a]quinoxaline derivatives as potential A2B receptor antagonists

Farag F. Sherbiny, Hamada S. Abulkhair, Hany G. Ezzat, 2020, Molecular Diversity.

Design, synthesis, biological assessment and molecular docking studies of some new 2-Thioxo-2,3-dihydropyrimidin-4(1H)-ones as potential anticancer and antibacterial agents

Farag F. Sherbiny, A. A. El-Etrawy, 2021 .

Synthesis, characterization and molecular docking studies of thiouracil derivatives as potent thymidylate synthase inhibitors and potential anticancer agents

Farag F. Sherbiny, I. Eissa, Abeer M. El-Naggar, 2017, Molecular Diversity.

Ligand-specific binding and activation of the human adenosine A(2B) receptor.

Farag F. Sherbiny, A. Schiedel, C. Müller, 2013, Biochemistry.

Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.

Farag F. Sherbiny, A. El-Morsy, M. Hagras, 2021, Bioorganic chemistry.

Design, synthesis, and molecular docking studies of new [1,2,4]triazolo[4,3-a]quinoxaline derivatives as potential A2B receptor antagonists

Farag F. Sherbiny, Hamada S. Abulkhair, Hany G. Ezzat, 2020, Molecular Diversity.

New potential anti-SARS-CoV-2 and anti-cancer therapies of chitosan derivatives and its nanoparticles: Preparation and characterization

Farag F. Sherbiny, A. Taher, H. M. Mohamed, 2023, Arabian Journal of Chemistry.

The four cysteine residues in the second extracellular loop of the human adenosine A2B receptor: role in ligand binding and receptor function.

Farag F. Sherbiny, A. Schiedel, C. Müller, 2011, Biochemical pharmacology.